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ABSTRACT
Background: At present, the only treatment for food allergy is to avoid the allergy-causing food. Some trials of
specific oral tolerance induction (SOTI) have been carried out, but the rate of tolerance induction was low de-
spite long treatment periods, at least 3 months to several years. A new type of treatment is long desired. The
objectives of this study are to perform our rush SOTI for school-age patients with severe egg allergy, and to
evaluate the safety and efficacy of this method for one year.
Methods: Six school-age children (7-12 years of age) with severe IgE-mediated egg allergy confirmed by
double-blind, placebo-controlled food challenge (DBPCFC) underwent rush SOTI, in which patients ingested
increasing doses of egg several times every day. After rush SOTI, patients ingested the maintenance dose of
egg at least twice a week.
Results: In DBPCFC, the median threshold dose of egg white inducing allergic reactions was 0.152 g (0.012-
0.360 g). All subjects acquired tolerance to more than one whole egg (60 g). It took only 12 days (9-18 days).
None experienced any serious reaction. We observed a decrease in IL-10 and an increase in TGF-β1 at 6
months and a decrease in egg-specific IgE and an increase in egg white-specific IgG4 at 12 months after rush
SOTI in blood. All subjects have been able to ingest more than one whole egg ever since.
Conclusions: Our rush SOTI is a safe and effective treatment for severe food allergy since only a few weeks
are needed to acquire tolerance. It would replace allergen avoidance as the treatment for food allergy.
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INTRODUCTION
Egg allergy is the most common food allergy in Japa-
nese children, affecting about 1 to 5% of young chil-
dren in prevalence, especially in immediate hypersen-
sitivity reactions.1 It can cause severe allergic reac-
tions in sensitized children.2,3 Although two thirds of
the children with egg allergy will outgrow their condi-
tion by the age of 6 years, most school-age patients
who have not developed tolerance by that age have
egg allergy for a long time.4,5
At present, the only treatment for food allergy is
the hope of outgrowing the food allergy while on an
allergen avoidance diet and education in case of acci-
dental ingestion of the causative food.6 However,
strict allergen avoidance can cause significant dietary
limitations. Previous studies have found that patients
with food allergy and their families have a signifi-
cantly reduced health-related quality of life.7,8 The
fear of unexpected and life-threatening reactions has
a very negative effect. Injection immunotherapy has
proven unsafe in food allergy9-12; in addition, anti-IgE
therapy is expensive and will not change the natural
history of allergic disease.13 In recent years, some tri-
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Table 1 Rush SOTI protocol
To ingest egg 3-5 times a day at 30-minute intervals.Rush SOTI
Start approximately at a tenth of the threshold dose determined at DBPCFC for each patient.Initial dose
Start with powdered egg white, the dose is increased approximately 1.2 fold every time.
When reaching 1,000 mg of powdered egg white, the material is changed to 8 g of heated egg (scrambled 
egg), and the dose is increased 1.5 fold every time up to 60 g.
If mild symptoms develop, the same dose or the previously tolerated dose is repeated.
If the symptoms are significant, rush SOTI is stopped.
Materials and
increase in dose
To ingest the maintenance dose of egg at least twice a week for maintenance.Maintenance
Perform oral chalenge test with 1 g of powdered egg at 9-12 months after starting maintenance.Chalenge test
als of specific oral tolerance induction (SOTI) in food
allergy have been carried out, but the rate of induc-
tion of tolerance was low despite long treatment peri-
ods and most of the subjects were very young chil-
dren, which made it difficult to differentiate actual ef-
fects of the treatment from natural outgrowth.14-20
Thus, a new type of safe and effective treatment is
eagerly desired.
Patients who react to aeroallergens can choose ac-
tive forms of treatment either through medication or
allergen specific immunotherapy. Allergen specific
immunotherapy induces tolerance to allergens, and it
can change the natural history of the disease.21,22
Rush injection of aeroallergen immunotherapy has
been performed in our hospital for more than 10
years for children. On the basis of our experiences
and prior studies, we realized rush immunotherapy
was very effective, because it allowed injection of a
high dose of the allergen in a short period.23,24 There-
fore, we thought that rush SOTI might induce toler-
ance better in patients with food-allergy during a
short period, and we prepared our rush SOTI proto-
col. In our protocol, the real threshold doses of egg at
which symptoms became evident were determined
by a double-blind, placebo-controlled food challenge
(DBPCFC) in all patients just before rush SOTI. So
we could clearly elucidate the changes of doses that
patients could tolerate in short periods during rush
SOTI.
METHODS
PATIENT SELECTION
We included school-age children with food allergy to
hen’s egg who had high levels of egg white-specific
IgE and a history of at least 1 severe allergic reaction
(i.e., reactions defined as grade 4 and 5 according to
the grading of food-induced anaphylaxis in Sampson’s
paper25) after accidental ingestion of small amounts
of heated egg (less than 2 g) requiring emergency
treatment within 1 year before the treatment. This
study protocol was approved by the Institutional Re-
view Board. Written informed consent was obtained
in accordance with the institution’s ethics guidelines
for research in children.
RUSH SOTI PROTOCOL
All subjects were hospitalized during all processes of
DBPCFC to the end of rush SOTI. Intramuscular
adrenaline, oral and intravenous antihistaminics, oxy-
gen, and bronchodilator for inhalation were ready to
be used at the bedside at all times.
DBPCFC:
We performed DBPCFC to confirm egg allergy. It
was carried out by administering placebo or pow-
dered hen’s egg white, “Dried egg white K type”, a
product of Q.P. Egg Corporation (Tokyo, Japan), dou-
bling the dose every 20 minutes. Not to confuse psy-
chological or mental reactions with a true positive re-
action in DBPCFC, only significant and objective
symptoms were considered to be positive allergic re-
actions as described by Niggemann and Beyer.26 A
single episode of vomiting was not taken as a positive
reaction, while severe and repetitive vomiting was
recognized as positive. If the DBPCFC was not posi-
tive, the patient was excluded.
Because the last dose of DBPCFC performed in a
mode mentioned above was not always the real
threshold for each subject, we repeated the challenge
test at the interval of 1 to 2 hours to determine the
real threshold dose until symptoms became evident.
Then, we started rush SOTI.
Rush SOTI:
Table 1 summarizes our rush SOTI protocol. The in-
itial dose of powdered hen’s egg white for each pa-
tient was set at approximately one tenth of the thresh-
old dose for that patient. After the initial dose, the
next and subsequent doses were increased approxi-
mately 1.2 times every time and administered every
30 minutes 3 to 5 times in one day or until the patient
developed a positive reaction. Powdered egg was
mixed with an acceptable vehicle food chosen by the
subject. When the dose reached 1 g of powdered egg,
which was equivalent to 8 g of real raw egg white, we
changed the material to heated egg starting at 8 g.
Scrambled egg heated at 70 to 82°C for 10 seconds
was used, because the powdered egg was not suitable
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for subjects to keep eating large dose everyday due to
its taste, and the aim of this therapy was to help sub-
jects to eat dishes and confectionery containing
heated egg in daily life. Thereafter, doses were in-
creased by approximately 1.5 times every time.
All patients were sent home every Saturday, Sun-
day and holiday for refreshment. To keep the effect of
rush SOTI, they were given the highest previously
tolerated dose, which was not increased at home,
three times a day in at least 1-hour intervals. We edu-
cated all caregivers about the nature of possible reac-
tions due to food allergy and the medical measures.
The goal of rush SOTI was one whole egg (about
60 g). If the subject reacted to one of the doses dur-
ing the course of rush SOTI and symptoms were
mild, then that dose or the previously tolerated dose
was repeated, and rush SOTI protocol proceeded.
But if severe adverse reactions such as anaphylaxis of
grade 5,25 marked dyspnea or cyanosis developed
once, or milder reactions were observed 3 times at
the same dose, the increase in dose of egg was aban-
doned. After taking the highest dose for 3 consecu-
tive days without developing any allergic reactions,
the rush SOTI was finished and that dose was chosen
as the maintenance dose.
Maintenance:
The subjects were discharged and instructed to in-
gest the maintenance dose of egg at least twice a
week at home to keep the effect of rush SOTI. Regu-
lar follow-up visits were planned.
EGG-SPECIFIC IgE, IgG4, HISTAMINE RELEASE
TEST, T HELPER 1T HELPER 2 RATIO, AND CY-
TOKINE CONCENTRATIONS
Blood samples were collected just before DBPCFC,
on the last day of rush SOTI and at 3, 6 and 12
months after starting maintenance. They were ana-
lyzed for egg white-specific serum IgE, ovomucoid-
specific serum IgE, egg white-specific serum IgG4,
histamine release test of egg white, T helper 1T
helper 2 ratio, and cytokines. Egg white-specific IgE
and ovomucoid-specific IgE were quantified using the
Phadia CAP System FEIA (Phadia, Uppsala, Swe-
den). Egg white-specific IgG4 was quantified using
the original ELISA system of SRL (SRL Inc., Tokyo,
Japan), whose measuring range is 25-800 UmL. His-
tamine release test of egg white was quantified using
“HRT Shionogi” (Shionogi, Osaka, Japan).27 T helper
1 (Th1, IFN-γ+IL-4-CD4)T helper 2 (Th2, IFN-γ-
IL-4+CD4) ratio assayed by the flow cytometry of
SRL (SRL Inc.).28 Serum IL-4, IL-10, and IFN-γ were
quantified using the original CLEIA system of SRL
(SRL Inc.), the Human IL-10 Ultra Sensitive ELISA
Kit (BioSource International, Camarillo, CA, USA),
and the Human IFN-γ ELISA (Bender MedSystems,
Vienna, Austria). Plasma TGF-β1 was quantified us-
ing the Quantikine Human TGF-β1 Immunoassay Kit
(R&D Systems, Minneapolis, MN, USA).
SKIN PRICK TEST
Skin prick test for egg-white was performed just be-
fore DBPCFC, on the last day of rush SOTI and at 3,
6 and 12 months after starting maintenance, using
“Allergen extracts for scratch test” (Torii Pharmaceu-
tical, Tokyo, Japan).
CHALLENGE OF POWDERED EGG DURING
MAINTENANCE PERIOD
We performed oral challenge test with 1 g of pow-
dered egg at 9 to 12 months after starting mainte-
nance.
STATISTICAL ANALYSIS
Wilcoxon signed-rank sum test (2-tailed, P < 0.05)
was used to evaluate the changes in IgE, IgG4, hista-
mine release test, Th1Th2 ratio, cytokine levels, and
the wheal size after the skin prick test.
RESULTS
SUBJECTS
Six subjects were initially enrolled. All of 6 subjects
had positive reactions in DBPCFC, and all patients
completed the study. Table 2 outlines patient charac-
teristics. There were 4 boys and 2 girls, the median
age was 9.7 years at the start of the study (range, 7-12
years), and all of them had experienced severe symp-
toms induced by dairy products containing small
amounts of heated egg (less than 2 g) within 1 year
before the treatment. All subjects had asthma and
atopic dermatitis, and 4 (67%) subjects had allergy to
at least one other food. The median threshold dose
(minimum dose inducing allergic reaction) of egg
white confirmed by DBPCFC was 0.152 g (range,
0.012-0.360 g), expressed as real egg white, and the
most common induced objective symptom was vomit-
ing (83%), the next being skin urticaria (50%). None
of the subjects responded to placebo.
RUSH SOTI
Table 3 summarizes the course of rush SOTI. Eventu-
ally, all subjects could tolerate more than 60 g of
heated egg at the end of rush SOTI, which took 12
days (range, 9-18 days). Patients stayed at home dur-
ing weekends and holidays, when they were asked to
keep ingestion of the fixed dose of egg white, hence
the actual number of days necessary to achieve toler-
ance to one whole egg was 9 days (7-13 days). Figure
1 shows the daily process of each subject to attain the
tolerance to 60 g of egg during rush SOTI. Sixty
grams of egg is equivalent to one whole egg of me-
dium size.
All children experienced some side-effects during
rush SOTI. These allergic symptoms which included
Itoh N et al.
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Table 2 Patient characteristics
Other
food
alergies
Complicati
ons
Symptoms
at DBPCFC
Threshold
dose‡ 
at DBPCFC
Recent history induced
by heated egg (< 2 g)†
 (age and symptoms)
AgeSexSubjectno.
Peanuts,
shelfish
Asthma, 
AD
AP, VO, UR,
SW, OP
0.360 g9 y 2 m 
AP, VO, DI, SW, OP
9 y 8 mF001
PeanutsAsthma, 
AD, AR
UR, DY, RH,
SN
0.012 g8 y 0 m
 UR, WH, DY
8 y 5 mM002
NoneAsthma, 
AD, AR
AP, VO, DI,
OP
0.296 g11 y 3 m
AP, VO, DI, UR, SW, OP
12 y 0 mM003
MilkAsthma, 
AD, AC
AP, VO, DI,
UR
0.200 g6 y 9 m
UR, SW, WH, DY
7 y 2 mF004
MilkAsthma, 
AD
AP, VO, OP0.088 g8 y 10 m
AP, VO, UR, WH, DY, OP
9 y 4 mM005
NoneAsthma, 
AD
AP, VO, OP0.104 g10 y 10 m
AP, VO, DI, UR, OP
11 y 4 mM006
0.152 g9 y 8 mMedian
AP, abdominal pain; VO, vomiting (severe and repetitive); DI, diarhea; UR, urticaria; SW, sweling; WH, wheeze; DY, dyspnea; RH, rhi
norhea; SN, sneezing; OP, oral pruritus; AD, atopic dermatitis; AR, alergic rhinitis; AC, alergic conjunctivitis.
†Al of subjects had the alergic reactions after ingestion of dairy products containing less than 2 g of heated egg requiring emergency 
treatment.
‡The dose is expressed as real egg white, though DBPCFC was performed with powdered egg white.
Table 3 Outcome of rush SOTI
Symptoms during
rush SOTI
Time to reach
60 g of egg
Tolerated dose † at the
end of rush SOTI
Threshold dose
at DBPCFC
Subject
no.
AP, UR, SW, WH, OP(13 days) ‡ 18 days>= 60 g0.360 g001
UR, RH, SN(9 days)13 days>= 60 g0.012 g002
AP, OP(7 days)9 days>= 60 g0.296 g003
UR, SW, WH, RH, SN(8 days)10 days>= 60 g0.200 g004
AP, DI, OP(11 days) 15 days>= 60 g0.088 g005
AP, DI, OP(9 days)11 days>= 60 g0.104 g006
(9 days) 12 days>= 60 g0.152 gMedian
AP, abdominal pain; DI, diarhea; UR, urticaria; SW, sweling; WH, wheeze; RH, rhinorhea; SN, sneezing; OP, oral pruritus.
†When reaching 1,000 mg of powdered egg white, which is equivalent to 8 g of real raw egg white, the material was changed to 8 g 
of heated egg (scrambled egg).
‡Figures in parentheses do not include the days the same dose was ingested at home during refreshment.
wheezing were found regardless of changes to scram-
bled egg in all patients. Mild symptoms, such as sole
urticaria, mild abdominal pain, and oral pruritus,
were controlled by oral antihistaminics if needed. No
vomiting was observed. Subjects 001 and 004 experi-
enced mild wheezing without dyspnea, once (day 11)
and twice (day 4 and day 9) respectively, and they re-
ceived single inhalation of a bronchodilator, which
brought prompt resolution of symptoms without
adrenaline treatment. Two subjects (005 and 006) ex-
perienced abdominal pain with single diarrhea once a
few hours after the dosing, and they were treated
with oral antihistaminics without further reactions.
Only one subject (004) received additional oral ster-
oid only once because she experienced severe urti-
caria all over her body. None of the subjects experi-
enced any serious reaction requiring adrenaline, in-
travenous fluids, or oxygen treatment.
All subjects are now between 16-21 months after
rush SOTI keeping ingestion of more than one
heated whole egg at least twice a week, and none of
them have symptoms.
As for the oral challenge test of 1 g of powdered
egg at 9 to 12 months after starting maintenance, 3 of
6 subjects tolerated with no symptom, 2 subjects re-
sponded with single vomiting, and the other re-
sponded with abdominal pain and single mild diar-
rhea, which did not apply to the positive allergic reac-
tion criteria in DBPCFC just before rush SOTI.
LABORATORY FINDINGS
Laboratory findings are shown in Figure 2. Egg
white-specific IgE levels tended to increase at the end
of rush SOTI, and thereafter began to decrease, had
tendencies to decrease, and decreased significantly at
12 months from rush SOTI compared with the levels
Rush SOTI in Severe Egg Allergy
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Fig. 1 Daily process to atain the tolerance to 60 g of egg during rush SOTI. The abscissa shows 
the days after starting rush SOTI. The ordinate shows the single doses ploted in logarithmic scale. 
The dose is expressed as real egg white. One gram of powdered egg white is equivalent to 8 g of real 
raw egg white. † When the dose reached 1 g of powdered egg white, we changed the material to 
scrambled egg starting at 8 g.
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before rush SOTI (P = 0.028). Ovomucoid-specific
IgE levels significantly decreased at 12 months after
rush SOTI, too (P = 0.028). Egg white-specific IgG4
levels increased significantly at 12 months after rush
SOTI (P = 0.043). Histamine release test of egg white
decreased in 4 subjects, while they did not decrease
in 2 subjects at 12 months after rush SOTI, and the
differences compared with the data before rush SOTI
were not significant. Th1Th2 ratio decreased signifi-
cantly at 6 months after rush SOTI (P = 0.047), but
the changes were not significant at 12 months. Serum
levels of IL-4 and IFN-γ did not change significantly
(data not shown). Serum levels of IL-10 decreased
and plasma levels of TGF-β1 increased from 6 months
after rush SOTI compared with the levels before rush
SOTI, and the changes were significant (P = 0.043
and P = 0.047 respectively). In regard to skin prick
test, the changes in skin prick test resulted in no sig-
nificant decrease (data not shown).
DISCUSSION
In recent years, several studies of SOTI have been re-
ported. Morisset et al.19 reported that oral desensiti-
zation helped allergic children to overcome their al-
lergy, while the avoidance of allergic foods was likely
to increase sensitization and to lower the threshold of
reactivity. But the efficacy rates for complete toler-
ance obtained in previous studies were between 36%
and 83%.14-20 Moreover, most of the subjects were
very young children and previous studies of SOTI
took a long time for treatment, at least 3 months to
several years, which made it difficult to differentiate
actual effects of the treatment from natural out-
growth. Longo et al.18 reported the data of SOTI for 1
year for cow’s milk allergy. They carried out the pro-
cedure as rush mode for the first 10 days, and the
success rate in this phase was only 30%. There are
few reports in this area in regard to acquisition of
complete tolerance in a very short period in patients
of school-age and over, except for some case re-
ports.29-31
Our study shows that our rush SOTI can induce
tolerance to the causative food in school-age patients
with severe food allergy in a few weeks. Although the
threshold dose of raw egg white at DBPCFC before
treatment was only 0.152 g (median), all subjects tol-
erated at least 8 g of raw egg white and they could
reach one whole heated egg (60 g) through rush
SOTI. Though subject number was not enough yet,
this success rate was 100%. Our experiences and
prior studies in rush immunotherapy for aeroaller-
gens and some successful reports about rapid desen-
sitization in patients with aspirin hypersensitivity
were hints for us to make our original rush SOTI pro-
tocol.23,24,32 We assume that the refractory state dur-
ing repeated exposure to the allergen may reduce the
Itoh N et al.
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Fig. 2 Laboratory findings. Blood samples were colected just before DBPCFC (before), on the last day of 
rush SOTI (after) and at 3 months (3M), at 6 months (6M) and at 12 months (12M) after starting 
maintenance. A, egg white-specific serum IgE. B, ovomucoid-specific serum IgE. C, egg white-specific se-
rum IgG4. D, histamine release test of egg white. E, T helper 1/T helper 2 ratio. F, serum IL-10. G, plasma 
TGF-β1. †A 24 U/mL value was assigned to <25 U/mL values (the lowest limit of detection of this 
technique). ‡T helper 1 (Th1, IFN-γ+/IL-4-/CD4); T helper 2 (Th2, IFN-γ-/IL-4+/CD4). §A 0.4 pg/mL value 
was assigned to <0.5 pg/mL values (the lowest limit of detection of this technique).
Rush SOTI in Severe Egg Allergy
Allergology International Vol 59, No1, 2010 www.jsaweb.jp 49
intensity of symptoms induced by the allergen,
though the precise mechanisms are not clear. Some
papers show immunologic unresponsiveness for a
short time after stimulation, which is called desensiti-
zation.33,34
In the literature on SOTI, side-effects are reported
in 50-100% of the cases.14-20 In our rush SOTI, all chil-
dren experienced side-effects to some extent. This re-
sult might be explained by the fact that all our pa-
tients had severe food allergy and they did not re-
ceive oral antihistaminics on a regular basis so as not
to mask any allergic reaction. The symptoms experi-
enced during rush SOTI period were easily con-
trolled by oral antihistaminics, except rare cases
which needed inhalation of beta agonist or oral corti-
costeroid. No subject required adrenaline, intrave-
nous fluids, or oxygen treatment. Furthermore, in
our rush SOTI, doses of food were increased only in
the hospital, so patients had no need to bother about
allergic reactions at home while many other studies
of SOTI caused reactions at home. Compared with
previous SOTI in children with severe food allergy,18
our rush SOTI seems to be safer, quicker and more
effective.
Many previous studies of SOTI in humans showed
that egg-specific serum IgE levels decreased once
oral tolerance was acquired14-20 and egg-specific se-
rum IgG4 levels increased15,20; this was not the case
in our study of rush SOTI. We found no statistical
changes in egg white-specific serum IgE levels and
ovomucoid-specific serum IgE levels at the end of
rush SOTI. Those changes appeared significantly af-
ter one year from rush SOTI. This strongly suggests
the mechanisms by which tolerance was acquired,
being independent of a decrease in specific IgE to the
allergen, during rush SOTI. Egg white-specific serum
IgG4 also increased significantly after more than 6
months. Only a few previous studies refer to skin
prick test, and they reported a decrease of the wheals
after a 6-month or more period of SOTI.15,16,19 We
found no significant decrease in skin prick test by
one year.
Though the mechanisms of SOTI in humans are
not clear yet, the mechanisms of oral tolerance in
mice were analyzed. Chehade and Mayer35 referred
to the relation between oral tolerance and the mu-
cosal immunologic organ. Oral tolerance can be in-
duced after administration of either a single high
dose of antigen or repeated lower doses. A high-dose
of an oral antigen can induce lymphocyte anergy or
deletion. Low-dose tolerance is mediated by regula-
tory T cells, such as TH3 cells, TR1 cells, CD4+ CD25+
cells, CD8+ cells and natural killer T cells, and by cy-
tokines, such as IL-10 and TGF-β. In our study, IL-10
decreased and TGF-β1 increased from 6 months after
rush SOTI. The role of TGF-β in the induction andor
maintenance of oral tolerance have been much de-
bated, with many reports suggesting an important
role for TGF-β.36,37 Previous reports on IL-10 showed
various data. Recent animal models of food allergy
demonstrated the important roles of IL-10 in oral tol-
erance.38,39 And Alonso et al. reported that increased
serum IL-10 level is a useful tool in the diagnosis of
food tolerance in previously food-allergic patients.40
Contrary to these papers, in our rush SOTI, IL-10 did
not seem to be an important factor for oral tolerance.
Some different mechanisms would induce oral toler-
ance. Some papers in which IL-10 did not appear to
be directly involved in the effecter or maintenance
phase of tolerance in animal models of oral tolerance
support these findings.36,41 Th1Th2 ratio decreased
significantly only at 6 months after rush SOTI in our
study in humans. Some papers reported both Th1
and Th2 responses were suppressed in animal mod-
els,36,41 but mechanisms of the phenomena were not
clear. Also the reason why histamine release caused
by egg white in blood of the subjects did not decrease
when the subjects could ingest the food without
symptoms is unknown.
Although our trial was an uncontrolled study, the
effect of this rush SOTI would be evident because we
identified symptoms by egg allergy by DBPCFC just
before the treatment, and it would be unlikely that
the allergic condition would vanish naturally in a few
weeks, especially at the ages of our subjects. All sub-
jects had had severe allergic reactions after ingestion
of less than 2 g of heated egg within 1 year before
this treatment, and in fact all of them had allergic
symptoms that included wheezing by ingestion of
scrambled egg during rush SOTI. However, at last all
of them could attain tolerance to more than one
whole egg. Further investigations are necessary to
analyze the precise mechanisms involved in the rapid
acquisition of tolerance to food and to improve the
practical procedures of this rush SOTI to be safer and
more effective. We will continue to follow and investi-
gate this phenomenon of our rush SOTI, and try to in-
crease subjects for this trial using egg and other
kinds of food.
In conclusion, we have shown that our rush SOTI
is a very effective and safe treatment for food allergy,
which induces oral tolerance during only 12 days in
school-age children with severe food allergy without
experiencing severe side effects. Although further
studies involving a large group of patients and thor-
ough analyses of the mechanisms are needed, we
consider that this method is a promising maneuver
that would replace allergen avoidance as the therapy
for food allergy.
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